Business Description
Arctic Bioscience AS
ISIN : NO0010859580
Description
Arctic Bioscience AS is a Norwegian biotechnology company. The company is focused on developing products and solutions based on bioactive marine compounds. The product portfolio includes nutraceuticals and pharmaceuticals. It is currently developing a novel, cost-efficient oral treatment (HRO350) for mild-to-moderate psoriasis. Its nutraceutical products are sold globally to both B2C and B2B under the Romega brand. The company operates in Norway, Europe, Australia and APAC.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 11.22 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 0.69 | |||||
| Beneish M-Score | -2.25 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.3 | |||||
| 3-Year EBITDA Growth Rate | -21.4 | |||||
| 3-Year EPS without NRI Growth Rate | -24.4 | |||||
| 3-Year FCF Growth Rate | -32.3 | |||||
| 3-Year Book Growth Rate | 57.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 15.41 | |||||
| 9-Day RSI | 29.66 | |||||
| 14-Day RSI | 34.86 | |||||
| 6-1 Month Momentum % | -82.04 | |||||
| 12-1 Month Momentum % | -79.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.06 | |||||
| Quick Ratio | 1.21 | |||||
| Cash Ratio | 0.55 | |||||
| Days Inventory | 540.41 | |||||
| Days Sales Outstanding | 145.48 | |||||
| Days Payable | 282.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.4 | |||||
| Shareholder Yield % | -2.23 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 29.2 | |||||
| Operating Margin % | -159.75 | |||||
| Net Margin % | -153.96 | |||||
| FCF Margin % | -298.83 | |||||
| ROE % | -18.67 | |||||
| ROA % | -16.21 | |||||
| ROIC % | -24.15 | |||||
| ROC (Joel Greenblatt) % | -123.75 | |||||
| ROCE % | -17.78 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.54 | |||||
| PB Ratio | 0.21 | |||||
| Price-to-Tangible-Book | 0.76 | |||||
| EV-to-EBIT | -0.65 | |||||
| EV-to-EBITDA | -0.74 | |||||
| EV-to-Revenue | 0.97 | |||||
| EV-to-FCF | -0.32 | |||||
| Price-to-Net-Current-Asset-Value | 1.33 | |||||
| Earnings Yield (Greenblatt) % | -153.85 | |||||
| FCF Yield % | -193.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arctic Bioscience AS Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2.741 | ||
| EPS (TTM) (€) | -0.166 | ||
| Beta | 2.39 | ||
| Volatility % | 103.17 | ||
| 14-Day RSI | 34.86 | ||
| 14-Day ATR (€) | 0.027073 | ||
| 20-Day SMA (€) | 0.13965 | ||
| 12-1 Month Momentum % | -79.22 | ||
| 52-Week Range (€) | 0.0835 - 1.23 | ||
| Shares Outstanding (Mil) | 25.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Arctic Bioscience AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Arctic Bioscience AS Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Arctic Bioscience AS Frequently Asked Questions
What is Arctic Bioscience AS(STU:9TD)'s stock price today?
The current price of STU:9TD is €0.11. The 52 week high of STU:9TD is €1.23 and 52 week low is €0.08.
When is next earnings date of Arctic Bioscience AS(STU:9TD)?
The next earnings date of Arctic Bioscience AS(STU:9TD) is 2025-02-28 Est..
Does Arctic Bioscience AS(STU:9TD) pay dividends? If so, how much?
Arctic Bioscience AS(STU:9TD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers